Vertex Pharmaceuticals (VRTX) P/E (2009 - 2026)
Vertex Pharmaceuticals (VRTX) P/E from Dec 31, 2009 to Jul 21, 2026. The TTM Vertex Pharmaceuticals (VRTX) P/E is 28.28. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Vertex Pharmaceuticals (VRTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 28.28 | -3.31% |
| 2025 | 29.25 | -114.97% |
| 2024 | -195.36 | -746.79% |
| 2023 | 30.20 | +33.87% |
| 2022 | 22.56 | -6.17% |
| 2021 | 24.04 | +6.17% |
| 2020 | 22.65 | -52.78% |
| 2019 | 47.96 | +137.86% |
| 2018 | 20.16 | -89.34% |
| 2017 | 189.10 | -327.11% |
| 2016 | -83.26 | +50.53% |
| 2015 | -55.31 | +44.06% |
| 2014 | -38.39 | +3.76% |
| 2013 | -37.00 | -57.30% |
| 2012 | -86.67 | +297.13% |
| 2011 | -21.82 | +131.78% |
| 2010 | -9.42 | -82.57% |
| 2009 | -54.01 | N/A |
Comparison Vertex Pharmaceuticals (VRTX) P/E with competitors
Vertex Pharmaceuticals (VRTX) P/E is 28.28.